Alpha DNA Investment Management’s Travelers Companies TRV Stock Holding History

Alpha DNA Investment Management’s Portfolio TRV Stock Details TRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$237K	Hold	885	–	–	2.64%	10
2025 Q1	$234K	Hold	885	–	–	3.06%	9
2024 Q4	$213K	Sell	885 -200	-18%	-$49.9K	0.08%	186
2024 Q3	$254K	Hold	1,085	–	–	0.1%	189
2024 Q2	$221K	Hold	1,085	–	–	0.09%	199
2024 Q1	$250K	Hold	1,085	–	–	0.09%	188
2023 Q4	$207K	Buy	+1,085	New	+$188K	0.08%	179
2021 Q2	–	Sell	-1,085	Closed	-$163K	–	609
2021 Q1	$163K	Buy	1,085 +43	+4%	+$6.32K	0.19%	105
2020 Q4	$146K	Buy	+1,042	New	+$134K	0.16%	114

Other funds holding TRV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Alpha DNA Investment Management's TRV Position: Q2 2025 in Review

Alpha DNA Investment Management held its Travelers Companies (TRV) position steady in Q2 2025 at 885 shares worth $237K. The position accounts for 2.64% of the portfolio, ranked #10.

Alpha DNA Investment Management first reported a position in TRV in Q4 2020 and has held it in 9 quarters since. The position peaked at $254K in Q3 2024. 1,629 funds tracked by Wall St. Rank hold TRV as of Q2 2025.

Alpha DNA Investment Management held 885 shares of Travelers Companies worth $237K as of Q2 2025.
Alpha DNA Investment Management left its Travelers Companies share count unchanged in Q2 2025.
Travelers Companies made up 2.64% of Alpha DNA Investment Management's portfolio in Q2 2025, its #10 holding.
Alpha DNA Investment Management first reported a position in Travelers Companies in Q4 2020 and has held it in 9 quarters since.
Alpha DNA Investment Management's Travelers Companies position peaked at $254K in Q3 2024.
1,629 funds tracked by Wall St. Rank held Travelers Companies as of Q2 2025.

Based on Alpha DNA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.